Dolnooravska Nemocnica S Poliklinikou Mudr. L. N. Jegeho
- Address
- lock Available on a paid plan
Musculoskeletal Diseases Research
At Dolnooravska Nemocnica S Poliklinikou Mudr. L. N. Jegeho, clinical research in Musculoskeletal Diseases focuses on moderate to severe rotator cuff tendinopathy, with studies aimed at improving shoulder symptoms and overall function for people living with persistent tendon-related pain.
- Testing whether a new therapy can better relieve shoulder pain and improve movement in patients with rotator cuff tendinopathy.
- Evaluating treatment effectiveness for physical shoulder symptoms in a common musculoskeletal condition affecting daily activity.
This work supports better care for patients with ongoing shoulder problems by exploring whether targeted treatment can provide greater symptom relief than current standard approaches.
Cardiovascular Diseases Research
The site also conducts studies in Cardiovascular Diseases that address prevention of ischemic stroke in patients after an acute non-cardioembolic ischemic stroke or a high-risk transient ischemic attack, reflecting a strong focus on reducing the risk of repeat events.
- Assessing whether a new oral treatment can help prevent another stroke in patients at elevated vascular risk.
- Comparing the safety and effectiveness of stroke-prevention strategies alongside standard antiplatelet therapy.
These trials aim to improve long-term protection against clot-related complications while also monitoring important safety outcomes such as major bleeding.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Pharmacosmos A/S1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dolnooravska Nemocnica S Poliklinikou Mudr. L. N. Jegeho
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of Secukinumab 300 mg Subcutaneous in Adults with Moderate to Severe Rotator Cuff Tendinopathy | Novartis Pharma AG | Phase III | Not Recruiting | Nov 2023 | Oct 2024 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Asundexian | 1 | Unknown | 2023-01-18 | 2023-01-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.